Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Botulinum Toxin Treatment in Craniofacial, Inguinal, Palmar, Plantar and Truncal Hyperhidrosis, a Randomized, Double Blind, Placebo Controlled Study

NCT01930604 is registered in ClinicalTrials.gov with Carl Swartling as lead sponsor.

Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01930604 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Botulinum Toxin Treatment in Craniofacial, Inguinal, Palmar, Plantar and Truncal Hyperhidrosis, a Randomized, Double Blind, Placebo Controlled Study
Lead sponsor
Carl Swartling
Phase
Phase 2
Overall status
Unknown status
Start date
September 30, 2013
Completion date
October 31, 2019
Enrollment
588 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.